Physician

Nishant K. Nerella, MD

According to 2025 Medicare claims, Nishant Nerella, MD (NPI: 1467659599) practices cardiology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is CITRUS CARDIOLOGY CONSULTANTS, PLLC (NPI: 1669405379; TIN: 59-2123944) and primary practice location at 34461-9223. Nerella is affiliated with the Health First Physicians ACO (ACO ID: A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (ACO ID: D0048), participating under both the MSSP and REACH models.

Nerella's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,380 traditional Medicare patients, billed 14,881 HCPCS/CPT codes, and received $1,128,353 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,821 prescription claims across 1,539 beneficiaries totaling $2,198,817 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 45 claims. Open Payments data shows 31 records totaling $628. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $558,443 to $1,128,353. Similarly, Part D prescription costs have moved sharply higher in recent years, from $261,417 to $2,198,817. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,428	7,122	$558,443
2016	1,660	8,123	$580,189
2017	2,204	8,818	$586,319
2018	2,347	10,027	$674,351
2019	3,256	11,782	$663,628
2020	2,529	10,306	$672,608
2021	2,231	10,611	$768,587
2022	2,160	10,708	$722,996
2023	2,370	12,956	$1,029,722
2024	2,380	14,881	$1,128,353

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	594	3,345	$261,417
2016	689	3,813	$338,965
2017	786	4,484	$459,147
2018	982	5,407	$768,419
2019	1,142	6,231	$1,029,424
2020	1,197	6,658	$1,219,329
2021	1,421	8,252	$1,376,751
2022	1,430	9,080	$1,845,863
2023	1,462	8,462	$2,060,386
2024	1,539	8,821	$2,198,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	45	$50,944
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	818	826	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,353	2,860	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	446	485	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,286	2,486	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	440	499	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	536	36,042	$680,124
Entresto	Sacubitril/Valsartan	356	21,034	$412,634
Farxiga	Dapagliflozin Propanediol	279	16,802	$309,055
Xarelto	Rivaroxaban	262	17,005	$305,631
Jardiance	Empagliflozin	90	5,102	$96,673

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$628	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nishant K. Nerella, MD?

Tedicare shows public-source Medicare data for Nishant K. Nerella, MD (NPI 1467659599), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nishant K. Nerella, MD have ACO affiliation data?

Nishant K. Nerella, MD is shown with ACO affiliation data for Health First Physicians ACO (MSSP, ACO ID A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (REACH, ACO ID D0048).

What billing organization is linked to Nishant K. Nerella, MD?

Nishant K. Nerella, MD is linked to CITRUS CARDIOLOGY CONSULTANTS, PLLC (billing NPI 1669405379) in the available physician profile data.

Does Nishant K. Nerella, MD have Open Payments data?

Nishant K. Nerella, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.